Categories
All News

Oncology Drugs Market to Witness Massive Growth During 2021-2027 | Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Bristol-Myers Squibb, Johnson & Johnson, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec, Teva, Otsuka, Eisai, Merck KGaA, Gilead Sciences

 Oncology Drugs  Market Research Report

LOS ANGELES, United States: QY Research has recently published a research report titled, “Global Oncology Drugs Market Size, Status and Forecast 2021-2027“. This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Oncology Drugs market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Oncology Drugs market.

The report includes CAGR, market shares, sales, gross margin, value, volume, and other vital market figures that give an exact picture of the growth of the global Oncology Drugs market.

Top Companies/Manufacturers:
Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Bristol-Myers Squibb, Johnson & Johnson, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec, Teva, Otsuka, Eisai, Merck KGaA, Gilead Sciences
Market Segment by Product Type:
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
According to the type, the income of chemotherapy is the highest, reaching 51.31% in 2019. Oncology Drugs
Market Segment by Application:
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
According to the application, blood cancer has the highest share of revenue, more than 22 percent in 2019.


Get PDF Sample Copy of the Report @

https://www.qyresearch.com/sample-form/form/2627227/global-oncology-drugs-market

For Customization in the Report Drop Your Query Here:

https://www.qyresearch.com/customize-request/form/2627227/global-oncology-drugs-market

Buy Now:

https://www.qyresearch.com/settlement/pre/ccc7e56b19462c26a1e924c730a3a1fa,0,1,global-oncology-drugs-market


Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Oncology Drugs market.

Key questions answered in the report:

  • What is the growth potential of the Oncology Drugs market?
  • Which product segment will grab a lion’s share?
  • Which regional market will emerge as a frontrunner in the coming years?
  • Which application segment will grow at a robust rate?
  • What are the growth opportunities that may emerge in the Oncology Drugs industry in the years to come?
  • What are the key challenges that the global Oncology Drugs market may face in the future?
  • Which are the leading companies in the global Oncology Drugs market?
  • Which are the key trends positively impacting the market growth?
  • Which are the growth strategies considered by the players to sustain hold in the global Oncology Drugs market

TOC

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy (Biologic Therapy)
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends
2.1 Global Oncology Drugs Market Perspective (2016-2027)
2.2 Oncology Drugs Growth Trends by Regions
2.2.1 Oncology Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oncology Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Oncology Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Oncology Drugs Industry Dynamic
2.3.1 Oncology Drugs Market Trends
2.3.2 Oncology Drugs Market Drivers
2.3.3 Oncology Drugs Market Challenges
2.3.4 Oncology Drugs Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Oncology Drugs Players by Revenue
3.1.1 Global Top Oncology Drugs Players by Revenue (2016-2021)
3.1.2 Global Oncology Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncology Drugs Revenue
3.4 Global Oncology Drugs Market Concentration Ratio
3.4.1 Global Oncology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Drugs Revenue in 2020
3.5 Oncology Drugs Key Players Head office and Area Served
3.6 Key Players Oncology Drugs Product Solution and Service
3.7 Date of Enter into Oncology Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Oncology Drugs Breakdown Data by Type
4.1 Global Oncology Drugs Historic Market Size by Type (2016-2021)
4.2 Global Oncology Drugs Forecasted Market Size by Type (2022-2027) 5 Oncology Drugs Breakdown Data by Application
5.1 Global Oncology Drugs Historic Market Size by Application (2016-2021)
5.2 Global Oncology Drugs Forecasted Market Size by Application (2022-2027) 6 North America
6.1 North America Oncology Drugs Market Size (2016-2027)
6.2 North America Oncology Drugs Market Size by Type
6.2.1 North America Oncology Drugs Market Size by Type (2016-2021)
6.2.2 North America Oncology Drugs Market Size by Type (2022-2027)
6.2.3 North America Oncology Drugs Market Size by Type (2016-2027)
6.3 North America Oncology Drugs Market Size by Application
6.3.1 North America Oncology Drugs Market Size by Application (2016-2021)
6.3.2 North America Oncology Drugs Market Size by Application (2022-2027)
6.3.3 North America Oncology Drugs Market Size by Application (2016-2027)
6.4 North America Oncology Drugs Market Size by Country
6.4.1 North America Oncology Drugs Market Size by Country (2016-2021)
6.4.2 North America Oncology Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada 7 Europe
7.1 Europe Oncology Drugs Market Size (2016-2027)
7.2 Europe Oncology Drugs Market Size by Type
7.2.1 Europe Oncology Drugs Market Size by Type (2016-2021)
7.2.2 Europe Oncology Drugs Market Size by Type (2022-2027)
7.2.3 Europe Oncology Drugs Market Size by Type (2016-2027)
7.3 Europe Oncology Drugs Market Size by Application
7.3.1 Europe Oncology Drugs Market Size by Application (2016-2021)
7.3.2 Europe Oncology Drugs Market Size by Application (2022-2027)
7.3.3 Europe Oncology Drugs Market Size by Application (2016-2027)
7.4 Europe Oncology Drugs Market Size by Country
7.4.1 Europe Oncology Drugs Market Size by Country (2016-2021)
7.4.2 Europe Oncology Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic 8 Asia-Pacific
8.1 Asia-Pacific Oncology Drugs Market Size (2016-2027)
8.2 Asia-Pacific Oncology Drugs Market Size by Type
8.2.1 Asia-Pacific Oncology Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oncology Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oncology Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Oncology Drugs Market Size by Application
8.3.1 Asia-Pacific Oncology Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oncology Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oncology Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Oncology Drugs Market Size by Region
8.4.1 Asia-Pacific Oncology Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oncology Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Oncology Drugs Market Size (2016-2027)
9.2 Latin America Oncology Drugs Market Size by Type
9.2.1 Latin America Oncology Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Oncology Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Oncology Drugs Market Size by Type (2016-2027)
9.3 Latin America Oncology Drugs Market Size by Application
9.3.1 Latin America Oncology Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Oncology Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Oncology Drugs Market Size by Application (2016-2027)
9.4 Latin America Oncology Drugs Market Size by Country
9.4.1 Latin America Oncology Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Oncology Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Oncology Drugs Market Size (2016-2027)
10.2 Middle East & Africa Oncology Drugs Market Size by Type
10.2.1 Middle East & Africa Oncology Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oncology Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oncology Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Oncology Drugs Market Size by Application
10.3.1 Middle East & Africa Oncology Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oncology Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oncology Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Oncology Drugs Market Size by Country
10.4.1 Middle East & Africa Oncology Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oncology Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Oncology Drugs Introduction
11.1.4 Roche Revenue in Oncology Drugs Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Oncology Drugs Introduction
11.2.4 Celgene Revenue in Oncology Drugs Business (2016-2021)
11.2.5 Celgene Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Oncology Drugs Introduction
11.3.4 Novartis Revenue in Oncology Drugs Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Oncology Drugs Introduction
11.4.4 Bristol-Myers Squibb Revenue in Oncology Drugs Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Oncology Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Oncology Drugs Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Merck & Co.
11.6.1 Merck & Co. Company Details
11.6.2 Merck & Co. Business Overview
11.6.3 Merck & Co. Oncology Drugs Introduction
11.6.4 Merck & Co. Revenue in Oncology Drugs Business (2016-2021)
11.6.5 Merck & Co. Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Oncology Drugs Introduction
11.7.4 AstraZeneca Revenue in Oncology Drugs Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Oncology Drugs Introduction
11.8.4 Pfizer Revenue in Oncology Drugs Business (2016-2021)
11.8.5 Pfizer Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Oncology Drugs Introduction
11.9.4 Amgen Revenue in Oncology Drugs Business (2016-2021)
11.9.5 Amgen Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Oncology Drugs Introduction
11.10.4 Eli Lilly Revenue in Oncology Drugs Business (2016-2021)
11.10.5 Eli Lilly Recent Development
11.11 AbbVie
11.11.1 AbbVie Company Details
11.11.2 AbbVie Business Overview
11.11.3 AbbVie Oncology Drugs Introduction
11.11.4 AbbVie Revenue in Oncology Drugs Business (2016-2021)
11.11.5 AbbVie Recent Development
11.12 Takeda
11.12.1 Takeda Company Details
11.12.2 Takeda Business Overview
11.12.3 Takeda Oncology Drugs Introduction
11.12.4 Takeda Revenue in Oncology Drugs Business (2016-2021)
11.12.5 Takeda Recent Development
11.13 Astellas
11.13.1 Astellas Company Details
11.13.2 Astellas Business Overview
11.13.3 Astellas Oncology Drugs Introduction
11.13.4 Astellas Revenue in Oncology Drugs Business (2016-2021)
11.13.5 Astellas Recent Development
11.14 Ipsen
11.14.1 Ipsen Company Details
11.14.2 Ipsen Business Overview
11.14.3 Ipsen Oncology Drugs Introduction
11.14.4 Ipsen Revenue in Oncology Drugs Business (2016-2021)
11.14.5 Ipsen Recent Development
11.15 Sanofi
11.15.1 Sanofi Company Details
11.15.2 Sanofi Business Overview
11.15.3 Sanofi Oncology Drugs Introduction
11.15.4 Sanofi Revenue in Oncology Drugs Business (2016-2021)
11.15.5 Sanofi Recent Development
11.16 Bayer
11.16.1 Bayer Company Details
11.16.2 Bayer Business Overview
11.16.3 Bayer Oncology Drugs Introduction
11.16.4 Bayer Revenue in Oncology Drugs Business (2016-2021)
11.16.5 Bayer Recent Development
11.17 Biogen Idec
11.17.1 Biogen Idec Company Details
11.17.2 Biogen Idec Business Overview
11.17.3 Biogen Idec Oncology Drugs Introduction
11.17.4 Biogen Idec Revenue in Oncology Drugs Business (2016-2021)
11.17.5 Biogen Idec Recent Development
11.18 Teva
11.18.1 Teva Company Details
11.18.2 Teva Business Overview
11.18.3 Teva Oncology Drugs Introduction
11.18.4 Teva Revenue in Oncology Drugs Business (2016-2021)
11.18.5 Teva Recent Development
11.18 Otsuka
.1 Otsuka Company Details
.2 Otsuka Business Overview
.3 Otsuka Oncology Drugs Introduction
.4 Otsuka Revenue in Oncology Drugs Business (2016-2021)
.5 Otsuka Recent Development
11.20 Eisai
11.20.1 Eisai Company Details
11.20.2 Eisai Business Overview
11.20.3 Eisai Oncology Drugs Introduction
11.20.4 Eisai Revenue in Oncology Drugs Business (2016-2021)
11.20.5 Eisai Recent Development
11.21 Merck KGaA
11.21.1 Merck KGaA Company Details
11.21.2 Merck KGaA Business Overview
11.21.3 Merck KGaA Oncology Drugs Introduction
11.21.4 Merck KGaA Revenue in Oncology Drugs Business (2016-2021)
11.21.5 Merck KGaA Recent Development
11.22 Gilead Sciences
11.22.1 Gilead Sciences Company Details
11.22.2 Gilead Sciences Business Overview
11.22.3 Gilead Sciences Oncology Drugs Introduction
11.22.4 Gilead Sciences Revenue in Oncology Drugs Business (2016-2021)
11.22.5 Gilead Sciences Recent Development 12 Analyst’s Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.